Naoxintong capsule delay the progression of diabetic kidney disease: A real-world cohort study.

ABSTRACT:

Introduction

Diabetic kidney disease (DKD) is a severe and growing health problem, associated with a worse prognosis and higher overall mortality rates than non-diabetic renal disease. Chinese herbs possess promising clinical benefits in alleviating the progression of DKD due to their multi-target effect. This real-world retrospective cohort trial aimed to investigate the efficacy and safety of Naoxintong (NXT) capsules in the treatment of DKD. Our study is the first real-world study (RWS) of NXT in the treatment of DKD based on a large database, providing a basis for clinical application and promotion.

Methods

The data was collected from Tianjin Healthcare and Medical Big Data Platform. Patients with DKD were enrolled from January 1, 2011, to March 31, 2021. NXT administrat

SUBMITTER: Zhang Y 

PROVIDER: S-EPMC9686849 | biostudies-literature | 2022

REPOSITORIES: biostudies-literature